Literature DB >> 3175536

The effect of starch malabsorption on fecal short-chain fatty acid excretion in man.

W Scheppach1, C Fabian, M Sachs, H Kasper.   

Abstract

To study the impact of starch malabsorption on fecal short-chain fatty acid concentrations, 11 healthy volunteers consumed a controlled diet rich in starch for 2 4-week periods. They received the glucosidase inhibitor acarbose (Bay g 5421) in one of the study periods and placebo in the other. Stool wet weight increased by 68% and stool dry weight by 57% with acarbose. The fecal concentration (mumol/g wet weight) of n-butyrate (+58%) rose significantly when acarbose was added to the diet. The fecal excretion (mmol/day) of total short-chain fatty acids (+95%) and of their constituents acetate (+97%) and n-butyrate (+182%) was significantly higher when starch malabsorption was induced by acarbose.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3175536     DOI: 10.3109/00365528809093945

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  13 in total

Review 1.  Pharmacokinetic-pharmacodynamic relationships of Acarbose.

Authors:  T Salvatore; D Giugliano
Journal:  Clin Pharmacokinet       Date:  1996-02       Impact factor: 6.447

2.  Changes of fermentation pathways of fecal microbial communities associated with a drug treatment that increases dietary starch in the human colon.

Authors:  M J Wolin; T L Miller; S Yerry; Y Zhang; S Bank; G A Weaver
Journal:  Appl Environ Microbiol       Date:  1999-07       Impact factor: 4.792

3.  Only fibres promoting a stable butyrate producing colonic ecosystem decrease the rate of aberrant crypt foci in rats.

Authors:  P Perrin; F Pierre; Y Patry; M Champ; M Berreur; G Pradal; F Bornet; K Meflah; J Menanteau
Journal:  Gut       Date:  2001-01       Impact factor: 23.059

4.  Relations between transit time, fermentation products, and hydrogen consuming flora in healthy humans.

Authors:  L El Oufir; B Flourié; S Bruley des Varannes; J L Barry; D Cloarec; F Bornet; J P Galmiche
Journal:  Gut       Date:  1996-06       Impact factor: 23.059

5.  A randomized placebo-controlled prevention trial of aspirin and/or resistant starch in young people with familial adenomatous polyposis.

Authors:  John Burn; D Timothy Bishop; Pamela D Chapman; Faye Elliott; Lucio Bertario; Malcolm G Dunlop; Diana Eccles; Anthony Ellis; D Gareth Evans; Riccardo Fodde; Eamonn R Maher; Gabriela Möslein; Hans F A Vasen; Julie Coaker; Robin K S Phillips; Steffen Bülow; John C Mathers
Journal:  Cancer Prev Res (Phila)       Date:  2011-05

6.  Effects of high-lipase pancreatin on fecal fat, neutral sterol, bile acid, and short-chain fatty acid excretion in patients with pancreatic insufficiency resulting from chronic pancreatitis.

Authors:  T Nakamura; Y Tandoh; A Terada; N Yamada; T Watanabe; A Kaji; K Imamura; H Kikuchi; T Suda
Journal:  Int J Pancreatol       Date:  1998-02

7.  Colonic dysfunction in acute diarrhoea: the role of luminal short chain fatty acids.

Authors:  B S Ramakrishna; V I Mathan
Journal:  Gut       Date:  1993-09       Impact factor: 23.059

8.  Colonic fermentation of potato starch after a freeze-thaw cycle.

Authors:  W Scheppach; M Bach; P Bartram; S Christl; W Bergthaller; H Kasper
Journal:  Dig Dis Sci       Date:  1991-11       Impact factor: 3.199

Review 9.  Diet and large bowel cancer.

Authors:  S A Bingham
Journal:  J R Soc Med       Date:  1990-07       Impact factor: 18.000

10.  Intestinal fermentation in patients with self-reported food hypersensitivity: painful, but protective?

Authors:  Jørgen Valeur; Mette Helvik Morken; Elisabeth Norin; Tore Midtvedt; Arnold Berstad
Journal:  Clin Exp Gastroenterol       Date:  2010-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.